A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Disorder of Consciousness
Interventions
DRUG

Zolpidem Tartrate Tablets

All participants were administered 10 mg of zolpidem tartrate tablets either via a feeding tube (for patients with prolonged disorders of consciousness) or orally.

Trial Locations (1)

710032

Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
collaborator

Guangzhou University of Chinese Medicine

OTHER

collaborator

University of Melbourne

OTHER

collaborator

Tianjin University

OTHER

lead

Xijing Hospital

OTHER

NCT02948660 - A Promising Tool for Predicting Consciousness Evolution in Prolonged Disorders of Consciousness | Biotech Hunter | Biotech Hunter